- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 726581, 13 pages
Biological Activities of Phosphocitrate: A Potential Meniscal Protective Agent
1Department of Orthopedic Research Biology, Cannon Research, Carolinas Medical Center, P.O. Box 32861, Charlotte, NC 28232, USA
2Dixon Advanced Analytics Group, Carolinas Medical Center, P.O. Box 32861, Charlotte, NC 28232, USA
Received 18 March 2013; Revised 12 June 2013; Accepted 19 June 2013
Academic Editor: Toshihiro Nanki
Copyright © 2013 Yubo Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. D. Bennett and J. C. Buckland-Wright, “Meniscal and articular cartilage changes in knee osteoarthritis: a cross-sectional double-contrast macroradiograpahic study,” Rheumatology, vol. 41, no. 8, pp. 917–923, 2002.
- D. J. Hunter, Y. Q. Zhang, X. Tu et al., “Change in joint space width: hyaline articular cartilage loss or alteration in meniscus?” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2488–2495, 2006.
- M. Englund, A. Guermazi, F. W. Roemer et al., “Meniscal tear in knees without surgery and the development of radiographic osteoarthritis among middle-aged and elderly persons: the multicenter osteoarthritis study,” Arthritis and Rheumatism, vol. 60, no. 3, pp. 831–839, 2009.
- Y. Sun, D. R. Mauerhan, P. R. Honeycutt et al., “Analysis of meniscal degeneration and meniscal gene expression,” BMC Musculoskeletal Disorders, vol. 11, article 19, 2010.
- Y. Sun and D. R. Mauerhan, “Meniscal calcification, pathogenesis and implications,” Current Opinion in Rheumatology, vol. 24, no. 2, pp. 152–157, 2012.
- M. Englund, A. Guermazi, and L. S. Lohmander, “The meniscus in knee osteoarthritis,” Rheumatic Disease Clinics of North America, vol. 35, no. 3, pp. 579–590, 2009.
- Y. Sun, D. R. Mauerhan, P. R. Honeycutt et al., “Calcium deposition in osteoarthritic meniscus and meniscal cell culture,” Arthritis Research and Therapy, vol. 12, no. 2, article R56, 2010.
- C. Pauli, S. P. Grogan, S. Patil et al., “Macroscopic and histopathologic analysis of human knee menisci in aging and osteoarthritis,” Osteoarthritis and Cartilage, vol. 19, no. 9, pp. 1132–1141, 2011.
- G. M. McCarthy, P. G. Mitchell, and H. S. Cheung, “The mitogenic response to stimulation with basic calcium phosphate crystals is accompanied by induction and secretion of collagenase in human fibroblasts,” Arthritis and Rheumatism, vol. 34, no. 8, pp. 1021–1030, 1991.
- Y. Sun, X. R. Zeng, L. Wenger, and H. S. Cheung, “Basic calcium phosphate crystals stimulate the endocytotic activity of cells—inhibition by anti-calcification agents,” Biochemical and Biophysical Research Communications, vol. 312, no. 4, pp. 1053–1059, 2003.
- M. P. Morgan, L. C. Whelan, J. D. Sallis, C. J. McCarthy, D. J. Fitzgerald, and G. M. McCarthy, “Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1β,” Arthritis and Rheumatism, vol. 50, no. 5, pp. 1642–1649, 2004.
- W. P. Tew, C. D. Malis, J. E. Howard, and A. L. Lehninger, “Phosphocitrate inhibits mitochondrial and cytosolic accumulation of calcium in kidney cells in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 9, pp. 5528–5532, 1981.
- L. Moro, N. Stagni, E. Luxich, J. D. Sallis, and B. De Bernard, “Evidence in vitro for an enzymatic synthesis of phosphocitrate,” Biochemical and Biophysical Research Communications, vol. 170, no. 1, pp. 251–258, 1990.
- M. Romanello, M. Michalsky, N. Stagni, L. Moro, D. Favretto, and P. Traldi, “High-performance liquid chromatographic and mass spectrometric identification of phosphocitrate synthesized by human kidney homogenate,” Journal of Chromatography, vol. 616, no. 2, pp. 167–173, 1993.
- G. Williams and J. D. Sallis, “Structure-activity relationship of inhibitors of hydroxyapatite formation,” Biochemical Journal, vol. 184, no. 1, pp. 181–184, 1979.
- G. Williams and J. D. Sallis, “Structural factors influencing the ability of compounds to inhibit hydroxyapatite formation,” Calcified Tissue International, vol. 34, no. 2, pp. 169–177, 1982.
- R. Shankar, S. Crowden, and J. D. Sallis, “Phosphocitrate and its analogue N-sulpho-2-amino tricarballylate inhibit aortic calcification,” Atherosclerosis, vol. 52, no. 2, pp. 191–198, 1984.
- D. Nair, R. P. Misra, J. D. Sallis, and H. S. Cheung, “Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway,” Journal of Biological Chemistry, vol. 272, no. 30, pp. 18920–18925, 1997.
- H. S. Cheung, J. D. Sallis, and J. A. Struve, “Specific inhibition of basic calcium phosphate and calcium pyrophosphate crystal-induction of metalloproteinase synthesis by phosphocitrate,” Biochimica et Biophysica Acta, vol. 1315, no. 2, pp. 105–111, 1996.
- Y. Sun, P. Reuben, L. Wenger, J. D. Sallis, K. D. Demadis, and H. S. Cheung, “Inhibition of calcium phosphate-DNA coprecipitates induced cell death by phosphocitrates,” Frontiers in Bioscience, vol. 10, pp. 803–808, 2005.
- H. S. Cheung, J. D. Sallis, K. D. Demadis, and A. Wierzbicki, “Phosphocitrate blocks calcification-induced articular joint degeneration in a guinea pig model,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2452–2461, 2006.
- M. Ding, C. C. Danielsen, and I. Hvid, “The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis,” Calcified Tissue International, vol. 82, no. 1, pp. 77–86, 2008.
- M. Walton, “The effects of long-term administration of ethane-1-hydroxy-1, 1-diphosphonate on osteoarthrosis and heterotopic ossification in the mouse knee joint,” Clinical Orthopaedics and Related Research, vol. 155, pp. 218–223, 1981.
- P. A. Turhanen, K. D. Demadis, S. Peräniemi, and J. J. Vepsäläinen, “A novel strategy for the preparation of naturally occurring phosphocitrate and its partially esterified derivatives,” Journal of Organic Chemistry, vol. 72, no. 4, pp. 1468–1471, 2007.
- H. J. Mankin and L. Lippiello, “Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips,” Journal of Bone and Joint Surgery A, vol. 52, no. 3, pp. 424–434, 1970.
- M. K. Lotz, S. Otsuki, S. P. Grogan, R. Sah, R. Terkeltaub, and D. D'Lima, “Cartilage cell clusters,” Arthritis and Rheumatism, vol. 62, no. 8, pp. 2206–2218, 2010.
- D. Pfander, D. Körtje, G. Weseloh, and B. Swoboda, “Cell proliferation in osteoarthritic human cartilage,” Zeitschrift fur Orthopadie und Ihre Grenzgebiete, vol. 139, no. 5, pp. 375–381, 2001.
- M. P. Hellio Le Graverand, P. Sciore, J. Eggerer et al., “Formation and phenotype of cell clusters in osteoarthritic meniscus,” Arthritis & Rheumatism, vol. 44, no. 8, pp. 1808–1818, 2001.
- S. Hashimoto, R. L. Ochs, S. Komiya, and M. Lotz, “Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis,” Arthritis & Rheumatism, vol. 41, no. 9, pp. 1632–1638, 1998.
- F. J. Blanco, R. Guitian, E. Vazquez-Martul, F. J. de Toro, and F. Galdo, “Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology,” Arthritis & Rheumatism, vol. 41, no. 2, pp. 284–289, 1998.
- K. Von der Mark, T. Kirsch, A. Nerlich et al., “Type X collagen synthesis in human osteoarthritic cartilage: indication of chondrocyte hypertrophy,” Arthritis and Rheumatism, vol. 35, no. 7, pp. 806–811, 1992.
- O. Pullig, G. Weseloh, D. L. Ronneberger, S. M. Käkönen, and B. Swoboda, “Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone,” Calcified Tissue International, vol. 67, no. 3, pp. 230–240, 2000.
- X. Wang, P. A. Manner, A. Horner, L. Shum, R. S. Tuan, and G. H. Nuckolls, “Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage,” Osteoarthritis and Cartilage, vol. 12, no. 12, pp. 963–973, 2004.
- K. Johnson, S. Hashimoto, M. Lotz, K. Pritzker, J. Goding, and R. Terkeltaub, “Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification,” Arthritis & Rheumatism, vol. 44, no. 5, pp. 1071–1081, 2001.
- C. Karlsson, T. Dehne, A. Lindahl et al., “Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis,” Osteoarthritis and Cartilage, vol. 18, no. 4, pp. 581–592, 2010.
- R. Ylönen, T. Kyrönlahti, M. Sund et al., “Type XIII collagen strongly affects bone formation in transgenic mice,” Journal of Bone and Mineral Research, vol. 20, no. 8, pp. 1381–1393, 2005.
- K. Ijiri, L. F. Zerbini, H. Peng et al., “Differential expression of GADD45β in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes,” Arthritis and Rheumatism, vol. 58, no. 7, pp. 2075–2087, 2008.
- C. A. Hellingman, E. N. B. Davidson, W. Koevoet et al., “Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8P prevents terminal differentiation and calcification,” Tissue Engineering A, vol. 17, no. 7-8, pp. 1157–1167, 2011.
- J. Zhang, Q. Tu, R. Grosschedl et al., “Roles of SATB2 in osteogenic differentiation and bone regeneration,” Tissue Engineering A, vol. 17, no. 13-14, pp. 1767–1776, 2011.
- J. Oyoung, Y. Liao, Y. Xiao et al., “Matrix gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals,” Journal of the American Chemical Society, vol. 133, no. 45, pp. 18406–18412, 2011.
- D. R. Clemmons, W. H. Busby Jr., A. Garmong et al., “Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis,” Arthritis and Rheumatism, vol. 46, no. 3, pp. 694–703, 2002.
- Z. Liu, K. J. Lavine, I. H. Hung, and D. M. Ornitz, “FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate,” Developmental Biology, vol. 302, no. 1, pp. 80–91, 2007.
- A. A. Zalutskaya, M. K. Cox, and M. B. Demay, “Phosphate regulates embryonic endochondral bone development,” Journal of Cellular Biochemistry, vol. 108, no. 3, pp. 668–674, 2009.
- N. B. Weksler, G. P. Lunstrum, E. S. Reid, and W. A. Horton, “Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro,” Biochemical Journal, vol. 342, part 3, pp. 677–682, 1999.
- A. Fakhry, C. Ratisoontorn, C. Vedhachalam et al., “Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential,” Bone, vol. 36, no. 2, pp. 254–266, 2005.
- T. O. Carpenter, B. K. Ellis, K. L. Insogna, W. M. Philbrick, J. Sterpka, and R. Shimkets, “Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 2, pp. 1012–1020, 2005.
- A. Ueno, Y. Miwa, K. Miyoshi et al., “Constitutive expression of thrombospondin 1 in MC3T3-E1 steoblastic cells inhibits mineralization,” Journal of Cellular Physiology, vol. 209, no. 2, pp. 322–332, 2006.
- J. L. Hsieh, P. C. Shen, A. L. Shiau et al., “Intraarticular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis,” Journal of Orthopaedic Research, vol. 28, no. 10, pp. 1300–1306, 2010.
- G. Valverde-Franco, J. S. Binette, W. Li et al., “Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice,” Human Molecular Genetics, vol. 15, no. 11, pp. 1783–1792, 2006.
- Y. Sun, D. R. Mauerhan, J. S. Kneisl et al., “Histological examination of collagen and proteoglycan changes in osteoarthritic menisci,” Open Rheumatology Journal, vol. 6, pp. 24–32, 2012.
- L. Leistad, A. J. Feuerherm, A. Faxvaag, and B. Johansen, “Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage,” Scandinavian Journal of Rheumatology, vol. 40, no. 4, pp. 308–316, 2011.
- N. Tai, K. Kuwabara, M. Kobayashi et al., “Cytosolic phospholipase A2 alpha inhibitor, pyrroxyphene, displays anti-arthritic and anti-bone destructive action in a murine arthritis model,” Inflammation Research, vol. 59, no. 1, pp. 53–62, 2010.
- S. C. Chu, S. F. Yang, K. H. Lue, Y. S. Hsieh, T. Y. Hsiao, and K. H. Lu, “Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee,” Journal of Rheumatology, vol. 33, no. 2, pp. 311–317, 2006.
- D. L. Boyle, J. Moore, L. Yang, L. S. Sorkin, and G. S. Firestein, “Spinal adenosine receptor activation inhibits inflammation and joint destruction in rat adjuvant-induced arthritis,” Arthritis and Rheumatism, vol. 46, no. 11, pp. 3076–3082, 2002.
- G. Y. Chen, J. Tang, P. Zheng, and Y. Liu, “CD24 and siglec-10 selectively repress tissue damage—induced immune responses,” Science, vol. 323, no. 5922, pp. 1722–1725, 2009.
- T. Seto, M. Yoshitake, T. Ogasawara et al., “Bcl6 in pulmonary epithelium coordinately controls the expression of the CC-type chemokine genes and attenuates allergic airway inflammation,” Clinical and Experimental Allergy, vol. 41, no. 11, pp. 1568–1578, 2011.
- Y. Sun, D. R. Mauerhan, A. M. Franklin, J. Norton, E. N. Hanley Jr., and H. E. Gruber, “Phosphocitrate is potentially a disease-modifying drug for noncrystal-associated osteoarthritis,” BioMed Research International, vol. 2013, Article ID 326267, 11 pages, 2013.
- S. Seshadri, Y. Kannan, S. Mitra, J. Parker-Barnes, and M. D. Wewers, “MAIL regulates human monocyte IL-6 production,” Journal of Immunology, vol. 183, no. 8, pp. 5358–5368, 2009.
- J. D. Levine, T. J. Coderre, C. Helms, and A. I. Basbaum, “β2-Adrenergic mechanisms in experimental arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 12, pp. 4553–4556, 1988.
- T. Nanki, T. Shimaoka, K. Hayashida, K. Taniguchi, S. Yonehara, and N. Miyasaka, “Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 52, no. 10, pp. 3004–3014, 2005.